Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network

American Journal of Kidney Diseases(2023)10.1053/j.ajkd.2022.11.012Source: DataRank Database

Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network is a research paper published in American Journal of Kidney Diseases (2023). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 1.77)OA: bronzeTopics (63)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (100)

Margaret Helmuth ORCID,Abigail R. Smith ORCID,Pietro A. Canetta ORCID,Isabelle Ayoub ORCID,Krzysztof Mucha ORCID

Live enrichment

PubMed:36608921 PMC:PMC10200745 OpenAlex:https://openalex.org/W4313463174

NIDDK NIH HHS

Grant: UM1 DK100846

NIDDK NIH HHS

Grant: UM1 DK100867

NIDDK NIH HHS

Grant: U01 DK100846

NIDDK NIH HHS

Grant: U01 DK100867

NIDDK NIH HHS

Grant: U24 DK100845

NIDDK NIH HHS

Grant: UM1 DK100876

NIDDK NIH HHS

Grant: T32 DK007750

NIDDK NIH HHS

Grant: U01 DK100876

NIDDK NIH HHS

Grant: UM1 DK100866

NIDDK NIH HHS

Grant: U01 DK100866

NIDDK NIH HHS

Grant: UM1 DK100845

NIH

FWCI

1.77

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.ajkd.org/article/S0272638623000021/pdf

BRONZEhttp://www.ajkd.org/article/S0272638623000021/pdf

publisherhttp://www.ajkd.org/article/S0272638623000021/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0272638623000021?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0272638623000021?httpAccept=text/plain

Fields of Study

Renal Diseases and GlomerulopathiesChronic Kidney Disease and DiabetesRenal Transplantation Outcomes and TreatmentsMedicineAdultChildAdolescentHumansNephrosis, LipoidRituximabAge of OnsetProspective StudiesDisease ProgressionNephrotic SyndromeBiopsyRecurrenceTreatment OutcomeRetrospective Studies

MeSH Terms

RituximabAdolescentAdultBiopsyChildHumansNephrosis, LipoidNephrotic SyndromeProspective StudiesRecurrenceRetrospective StudiesTreatment OutcomeAge of OnsetDisease Progression

Keywords

MedicineImmunosuppressionRituximabMinimal change diseaseKidney diseaseProportional hazards modelInternal medicineRenal functionNephrologyAge of onsetYoung adultBiopsyPediatricsDiseaseFocal segmental glomerulosclerosisProteinuriaKidneyChildrenPrognosisAdultsRelapseAdolescentsRemissionClinical PhenotypeDisease CourseEstimated Glomerular Filtration Rate (Egfr)Age At Disease OnsetNephrotic Syndrome (Ns)Clinical TrajectoryMinimal Change Disease (Mcd)Egfr Change

Sustainable Development Goals

SDG 0: Good health and well-being